Cargando…
Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma
BACKGROUND: Transfusion of platelets (PLTs) with high ABO antibody titres can pose a risk of hemolysis if the unit crosses the ABO type. The PLTs stored in the platelet additive solution (PAS) remove asubstantial fraction of plasma and replace it with an isotonicbuffered solution.We aimed to assess...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211627/ https://www.ncbi.nlm.nih.gov/pubmed/32571673 http://dx.doi.org/10.1016/j.htct.2020.03.008 |
_version_ | 1783709504678920192 |
---|---|
author | KC, Gayathiri Murugesan, Mohandoss Nayanar, Sangeetha K. Malodan, Riyas Padmanaban, Maya |
author_facet | KC, Gayathiri Murugesan, Mohandoss Nayanar, Sangeetha K. Malodan, Riyas Padmanaban, Maya |
author_sort | KC, Gayathiri |
collection | PubMed |
description | BACKGROUND: Transfusion of platelets (PLTs) with high ABO antibody titres can pose a risk of hemolysis if the unit crosses the ABO type. The PLTs stored in the platelet additive solution (PAS) remove asubstantial fraction of plasma and replace it with an isotonicbuffered solution.We aimed to assess the difference in anti-A/B antibody levels in Groups O, A and B apheresis platelets (APs) suspended in plasma and PAS. METHODOLOGY: Apheresis donors are categorized into two groups, Plasma (Group I) and PAS (Group II), each blood group (A, B and O) had 20 samples. The anti-A/B(IgM)antibody levels were recorded from the AP donor (Group II) and from the AP units for both groups. The reduction in the anti-A/B(IgM) antibody levels in the APs suspended in the PAS for each blood group was determined. RESULTS: The median anti-A titres in blood Groups B (p = 0.009) and O (p = 0.005) was significantly lower in Group II. However, the difference in anti-B levels was not significant in the blood groups A (p = 0.057) and O (p = 0.205). The median level of reduction in IgM antibody titres across donor samples and the PAS-stored platelets was two-fold. The regression showed a level of reduction in antibody titres which can be explained by baseline donor antibody titres in blood groups A and B compared to blood group O. CONCLUSION: The medianABO antibody titres were lower in APs suspended in PAS than in plasma. Addition of the PAS significantly lowered the IgM antibody titres by twofold, compared to plasma. |
format | Online Article Text |
id | pubmed-8211627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sociedade Brasileira de Hematologia e Hemoterapia |
record_format | MEDLINE/PubMed |
spelling | pubmed-82116272021-06-25 Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma KC, Gayathiri Murugesan, Mohandoss Nayanar, Sangeetha K. Malodan, Riyas Padmanaban, Maya Hematol Transfus Cell Ther Original Article BACKGROUND: Transfusion of platelets (PLTs) with high ABO antibody titres can pose a risk of hemolysis if the unit crosses the ABO type. The PLTs stored in the platelet additive solution (PAS) remove asubstantial fraction of plasma and replace it with an isotonicbuffered solution.We aimed to assess the difference in anti-A/B antibody levels in Groups O, A and B apheresis platelets (APs) suspended in plasma and PAS. METHODOLOGY: Apheresis donors are categorized into two groups, Plasma (Group I) and PAS (Group II), each blood group (A, B and O) had 20 samples. The anti-A/B(IgM)antibody levels were recorded from the AP donor (Group II) and from the AP units for both groups. The reduction in the anti-A/B(IgM) antibody levels in the APs suspended in the PAS for each blood group was determined. RESULTS: The median anti-A titres in blood Groups B (p = 0.009) and O (p = 0.005) was significantly lower in Group II. However, the difference in anti-B levels was not significant in the blood groups A (p = 0.057) and O (p = 0.205). The median level of reduction in IgM antibody titres across donor samples and the PAS-stored platelets was two-fold. The regression showed a level of reduction in antibody titres which can be explained by baseline donor antibody titres in blood groups A and B compared to blood group O. CONCLUSION: The medianABO antibody titres were lower in APs suspended in PAS than in plasma. Addition of the PAS significantly lowered the IgM antibody titres by twofold, compared to plasma. Sociedade Brasileira de Hematologia e Hemoterapia 2021 2020-06-15 /pmc/articles/PMC8211627/ /pubmed/32571673 http://dx.doi.org/10.1016/j.htct.2020.03.008 Text en © 2020 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article KC, Gayathiri Murugesan, Mohandoss Nayanar, Sangeetha K. Malodan, Riyas Padmanaban, Maya Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma |
title | Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma |
title_full | Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma |
title_fullStr | Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma |
title_full_unstemmed | Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma |
title_short | Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma |
title_sort | comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211627/ https://www.ncbi.nlm.nih.gov/pubmed/32571673 http://dx.doi.org/10.1016/j.htct.2020.03.008 |
work_keys_str_mv | AT kcgayathiri comparisonofaboantibodylevelsinapheresisplateletssuspendedinplateletadditivesolutionandplasma AT murugesanmohandoss comparisonofaboantibodylevelsinapheresisplateletssuspendedinplateletadditivesolutionandplasma AT nayanarsangeethak comparisonofaboantibodylevelsinapheresisplateletssuspendedinplateletadditivesolutionandplasma AT malodanriyas comparisonofaboantibodylevelsinapheresisplateletssuspendedinplateletadditivesolutionandplasma AT padmanabanmaya comparisonofaboantibodylevelsinapheresisplateletssuspendedinplateletadditivesolutionandplasma |